Oral Abstract Session
Hemodialysis: Novel Interventions
November 06, 2025 | 04:30 PM - 06:00 PM
Location: Room 351D, Convention Center
Session Description
Oral Abstract Session
Note: Continuing education credits are not being offered for this session.
Learning Pathway(s)
- Dialysis
Moderators
Presentations
- Effectiveness of Additional Strengthening Exercises Combined with Gabapentin in Managing Restless Legs Syndrome Among Patients on Hemodialysis: An Open-Label Randomized Controlled Trial
04:30 PM - 04:40 PM
- Win-Odds Analysis of Deaths and Hospitalization in Patients Taking Vadadustat or Darbepoetin Alfa for CKD-Related Anemia Undergoing Dialysis
04:40 PM - 04:50 PM
- Associations Between Antidiabetes Medications and Mortality in Patients on Dialysis: A National Study from Taiwan
04:50 PM - 05:00 PM
- Effects of Henagliflozin on Cardiac Structure in Patients with Heart Failure with Preserved Ejection Fraction Undergoing Dialysis: The HELD-HF Randomized Controlled Trial
05:00 PM - 05:10 PM
- SGLT2 Inhibitor Therapy on Clinical Outcomes in Patients with Type 2 Diabetes on Dialysis: Real-World Evidence Study
05:10 PM - 05:20 PM
- GLP-1 Receptor Agonist Use Associated with Improvement in Hospitalization Rates in Patients with ESKD
05:20 PM - 05:30 PM
- Hemodiafiltration Is Associated with Reduced Risk of Cardiovascular and Fluid-Related Hospitalization Outcomes
05:30 PM - 05:40 PM
- Long-Term Outcomes in Incident Patients on Incremental Hemodialysis vs. Standard Hemodialysis
05:40 PM - 05:50 PM
- Derivation and Validation of a Machine-Learning Decision Model for Incremental Hemodialysis: Emulating Expert Decision-Making
05:50 PM - 06:00 PM